Xeris Biopharma Holdings, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Xeris Biopharma Holdings, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Xeris Biopharma Holdings, Inc. Assets for the quarter ending September 30, 2024 was $321M, a 2.04% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$321M	-$6.68M	-2.04%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$332M	+$2.96M	+0.9%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$337M	+$15.3M	+4.75%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$323M	-$21.9M	-6.36%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$328M	+$24.8M	+8.17%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$329M	+$10.2M	+3.19%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$321M	-$16.3M	-4.82%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$345M	+$40.2M	+13.2%	Dec 31, 2022	10-K	2024-03-06
Q3 2022	$303M	+$172M	+131%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$319M			Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$338M			Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$304M	+$145M	+91.2%	Dec 31, 2021	10-K	2023-03-08
Q3 2021	$131M			Sep 30, 2021	10-Q	2021-11-10
Q4 2020	$159M			Dec 31, 2020	10-K	2022-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.